pregabalin
Generic: pregabalin
Labeler: cipla usa, inc.Drug Facts
Product Profile
Brand Name
pregabalin
Generic Name
pregabalin
Labeler
cipla usa, inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
pregabalin 225 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
69097-961
Product ID
69097-961_96d9d734-42e6-474d-a75e-0381de0a8ec1
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA211384
DEA Schedule
cv
Listing Expiration
2026-12-31
Marketing Start
2019-07-19
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
69097961
Hyphenated Format
69097-961
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
pregabalin (source: ndc)
Generic Name
pregabalin (source: ndc)
Application Number
ANDA211384 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 225 mg/1
Packaging
- 90 CAPSULE in 1 BOTTLE (69097-961-05)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "96d9d734-42e6-474d-a75e-0381de0a8ec1", "openfda": {"upc": ["0369097955052", "0369097957056", "0369097956059", "0369097958053", "0369097954055", "0369097962050", "0369097961053"], "unii": ["55JG375S6M"], "rxcui": ["483438", "483440", "483442", "483444", "483446", "483448", "483450", "577127"], "spl_set_id": ["17a8087c-579f-42de-ae92-006ea64def2a"], "manufacturer_name": ["Cipla USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 CAPSULE in 1 BOTTLE (69097-961-05)", "package_ndc": "69097-961-05", "marketing_start_date": "20190719"}], "brand_name": "Pregabalin", "product_id": "69097-961_96d9d734-42e6-474d-a75e-0381de0a8ec1", "dosage_form": "CAPSULE", "product_ndc": "69097-961", "dea_schedule": "CV", "generic_name": "PREGABALIN", "labeler_name": "Cipla USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pregabalin", "active_ingredients": [{"name": "PREGABALIN", "strength": "225 mg/1"}], "application_number": "ANDA211384", "marketing_category": "ANDA", "marketing_start_date": "20190719", "listing_expiration_date": "20261231"}